• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Catalent Pharma launches Catalent Applied Drug Delivery Institute

Catalent Pharma launches Catalent Applied Drug Delivery Institute

October 22, 2012
CenterWatch Staff

Catalent Pharma Solutions, a developer of solutions and advanced drug delivery technologies, has launched its Catalent Applied Drug Delivery Institute.

The Catalent Applied Drug Delivery Institute aspires to promote innovation, knowledge-sharing and collaboration between industry leaders, academic experts, customers and regulators to enhance understanding of available, emerging and future drug delivery technologies and improve patient care.

"The mission of the Catalent Applied Drug Delivery Institute is to bring better treatments to market by advancing the development and adoption of applied drug delivery technologies," said Kurt Nielsen, Ph.D., senior vice president of R&D, Catalent. "By harnessing the knowledge of some of the world's leading experts in drug development, delivery and formulation, the Institute will cultivate leadership and excellence in drug development through education, training and innovation."

As part of its mission, the Catalent Applied Drug Delivery Institute will serve as a link between industry and academia by providing guidance, counsel and resources on major issues pertaining to drug development, delivery and formulation. The Institute will develop programs that facilitate mutually beneficial collaborations, increase communication and shed light on regulatory issues affecting drug developers and researchers. It also will pursue a multi-tiered approach of seed funding, strategic counsel and educational programs to advance the adoption of emerging technologies.

"We hope to start an informative and productive dialog between industry and academic experts that will spur innovation at the benchtop and in the marketplace,” said Rao Tatapudy, vice president of scientific affairs, Catalent. “We look forward to a continuous series of successful collaborations as the Institute's activities unfold." 

There will be a series of Institute-led initiatives designed to enhance understanding of drug delivery and inspire the next generation of science leaders. These initiatives, which will target both industry and academic audiences, will include:

  • Applied drug delivery events and training programs for industry
  • Innovation and research collaborations with universities and technology companies
  • Catalent Applied Drug Delivery Institute Scientific Journal
  • Science Leaders of Tomorrow university partnership program
  • Student drug delivery guide
  • Annual drug delivery landscape technology survey
  • Scientific communications

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • MAGI East 2023

    MAGI East 2023 Preview: Janssen Reports on Environmental Impact of Trials

  • Complexity-360x240.png

    Phase 3 Trials Significantly Rising in Complexity, Says CSDD

  • Quality Level Scale

    Build Quality into Trials Like You’d Build a House, Says FDA’s BIMO Director

  • DE&I

    Trust-Building, Community Connection Still Essential to DE&I Efforts, Experts Say

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing